Home

GlycoMimetics, Inc. (GLYC)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about GlycoMimetics, Inc. (GLYC)

Go deeper and ask any question about GLYC

Company Performance

Current Price

as of Sep 13, 2024

$0.17

P/E Ratio

N/A

Market Cap

$10.96M

Description

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Metrics

Overview

  • HQRockville, MD
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerGLYC
  • Price$0.17+3.66%

Trading Information

  • Market Cap$10.96M
  • Float91.62%
  • Average Daily Volume (1m)1,037,398
  • Average Daily Volume (3m)3,808,795
  • EPS-$0.61

Company

  • Revenue$0.01M
  • Rev Growth (1yr)N/A
  • Net Income-$10.10M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$10.35M
  • EV-$3.78M
  • EV/Revenue-377.86
  • P/EN/A
  • P/S1,096.23
Documents